Error: Could not add to watchlist. X
+ Watchlist

BELLUS Health Inc

BHN:GR
Frankfurt
1.79
EUR
0.10
6.17%
As of 10:05 AM EDT 5/27/2016
Open
1.71
Day Range
1.71 - 1.79
Volume
0
Previous Close
1.69
52Wk Range
0.26 - 1.79
1 Yr Return
108.02%
Open
1.71
Day Range
1.71 - 1.79
Volume
0
Previous Close
1.69
52Wk Range
0.26 - 1.79
1 Yr Return
108.02%
YTD Return
190.42%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m EUR)
97.882
Shares Outstanding (m)
54.713
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BELLUS Health Inc. develops drugs for rare diseases, including conditions that affect the kidneys. The Company's main operations are in a Phase III Confirmatory Study for the treatment of AA amyloidosis. BELLUS is also developing treatments for sarcoidosis and hemolytic uremic syndrome.
Address
275 Armand-Frappier Boulevard
Laval, QC H7V 4A7
Canada
Phone
1-450-680-4500
Show More